About CHEManager and CHEManager International
The CHEManager brand of publications and information services comprises leading business newspapers and various online services for the chemical and pharmaceutical industry. The German-language print edition CHEManager was established in 1991 and has since become the must-read trade and business newspaper for executives and managers in the chemical and pharmaceutical markets in Germany, Austria and Switzerland.
In 2005, an English-language edition, named CHEManager Europe was added to provide top-level managers and executives outside of the German-language region in Europe with all relevant industry information. In January 2014, CHEManager Europe was renamed CHEManager International in order to reflect the global scope of the newspaper in terms of both content and reach.
With print circulations of 43,000 and 20,000 copies, respectively, both titles are the most powerful marketing and communication tools in their relevant markets. The editorial concepts enable CHEManager and CHEManager International to provide managers in Production, R&D, Sales and Marketing, Human Resources, Legal Affairs, Logistics, IT, and other departments of chemical/pharmaceutical companies with insightful interviews with industry decision makers, in-depth articles on the newest trends and developments and the latest market news.
The bi-lingual online B2B portal CHEManager.com supports the 26 print editions and informs visitors with daily news feeds, exclusive online content, and several digital services such as e-newsletters, webcasts, whitepapers, microsites, and social media networks about ongoings and developments in the global chemical and pharmaceutical industry.
About John Wiley & Sons and GIT Publishers
GIT Publishers, Darmstadt, Germany has published technical oriented B2B media for science, industry, technology and medicine since 1969 and is specialized in modern, practice-oriented trade journals, providing readers with know-how in the fields of chemistry, pharmaceuticals, biotechnology, laboratory, healthcare, automation and safety. GIT offers customers and readers high quality media and services in the print and online sector, as well as individual B-2-B services, such as corporate publishing and direct marketing. The family-owned publishing company was acquired by U.S. publishing group John Wiley and Sons in 2002.
Founded in 1807, John Wiley & Sons, Inc. has been a valued source of information and understanding for 200 years, helping people around the world meet their needs and fulfill their aspirations. Since 1901, Wiley and its acquired companies have published the works of more than 350 Nobel laureates in all categories: Literature, Economics, Physiology/Medicine, Chemistry and Peace. The core businesses include scientific, technical, medical and scholarly journals, encyclopedias, books, and online products and services; professional/trade publishes books, subscription products, training materials, online applications and websites; and educational materials for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, South America and Australia.
The Company is listed on the New York Stock Exchange under the symbols JWa and JWb. In February 2007 Wiley-Blackwell was formed as a result of the acquisition of U.K.-based Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley´s Scientific, Technical, and Medical business. Today, the Global research business unit of Wiley that includes the GIT business is the international scientific, technical, medical and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. For more information, please visit www.wiley.com.
Wiley-VCH Verlag GmbH & Co. KGaA
Publishing Manager / Editor in Chief
Tel.: +49 (0) 6201/606-745
Editor in Chief
Tel.: +49 (0) 6201/606-755
Tel.: +49 (0) 6151/660863
Dept.: Chemie * Life Sciences
Tel.: +49 (0) 961/7448-249
Tel.: +49 (0) 721/7880-038
Tel.: +49 (0) 6050/901633
Tel.: +49 (0) 2225/98089-35
Tel.: +49 (0) 170/6390063
Tel.: +49 (0) 6201/606-768
Tel.: +49 (0) 6201/606-714
Tel.: +49 (0) 6201/606-764
Tel.: +49 (0) 6201/606-316
Tel.: +49 (0) 6201/606-316